As the saying goes, bulls and bears make money. And today in these three Cathie Wood stocks both camps should be ready for action More
Articles
After Nasdaq Uplisting, PharmaCyte Biotech Looks Ready to Rumble
There's no denying that PMCB stock has lost much of its value over the years. However, recent developments could catalyze a price resurgence. More
The Pandemic Adds Unnecessary Pressure to MicroVision
While MVIS stock is tied to a groundbreaking innovation in autonomous driving, the pandemic has made its narrative more problematic. More
Nokia Is Worth Over $7.50 Given Its Performance and Outlook
Nokia looks very undervalued given its outlook. NOK stock is worth $7.59 based on its FCF estimates for 2021 sales and operating margin. More
XPeng Is A Strong Buy After Q2 Results
XPEV stock is the one to own as the company is on a massive expansion spree and has impressed investors with August delivery numbers. More
Stay Away From Ashford Hospitality Trust
AHT stock is dead money while the company struggles to address the cash traps in its portfolio. Do yourself a favor and check out for now. More